Clinuvel: Phase 3, Pfizer: Phase 3, AbbVie: Phase 3, Incyte: Phase 3, Amgen: Discontinued, Vyne Therapeutics: Discontinued (Phase 2b failed), Dermavant: Inactive, Pfizer: Phase 2, Edesa Biotech: Phase 2, Amgen: Discontinued, Sun Pharmaceutical: Phase 2, Jiangsu HengRui Medicine: Phase 2, Forte Biosciences: Phase 1b, Teva Pharmaceutical: Phase 1b, Dren Bio: Phase 1b

Clinuvel: Phase 3, Pfizer: Phase 3, AbbVie: Phase 3, Incyte: Phase 3, Amgen: Discontinued, Vyne Therapeutics: Discontinued (Phase 2b failed), Dermavant: Inactive, Pfizer: Phase 2, Edesa Biotech: Phase 2, Amgen: Discontinued, Sun Pharmaceutical: Phase 2, Jiangsu HengRui Medicine: Phase 2, Forte Biosciences: Phase 1b, Teva Pharmaceutical: Phase 1b, Dren Bio: Phase 1b

//The Vitiligo News

Bringing the latest news from all areas of the vitiligo space.

  • We love to investigate vitiligo because...

  • There is very little privately funded research going on.

  • Our breakthroughs help answer questions that other people don’t even want to ask.

  • It changes our relationship with vitiligo, empowering us to be responsible and not victims.

  • We are thinking about the future generations of children who will have vitiligo.

  • it's fun!

  • We invite you to join us in our mission to make a massive contribution to vitiligo investigation.

  • Scroll down to start.

Coming 2026

//The Vitiligo State of Mind

Will you answer the call to help make a massive contribution to vitiligo investigation?

Want to talk to us about your vitiligo situation?

//The Vitiligo Thoughts

Who can imagine what would happen if hundreds of people came together to independently investigate vitiligo in an organised and intentional way…